206 related articles for article (PubMed ID: 28577912)
1. Targeting survivin for therapeutic discovery: past, present, and future promises.
Peery RC; Liu JY; Zhang JT
Drug Discov Today; 2017 Oct; 22(10):1466-1477. PubMed ID: 28577912
[TBL] [Abstract][Full Text] [Related]
2. Targeting survivin in cancer: the cell-signalling perspective.
Kanwar JR; Kamalapuram SK; Kanwar RK
Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.
Cui Q; Huang C; Liu JY; Zhang JT
J Med Chem; 2023 Dec; 66(24):16515-16545. PubMed ID: 38092421
[TBL] [Abstract][Full Text] [Related]
4. IAP antagonists: promising candidates for cancer therapy.
Mannhold R; Fulda S; Carosati E
Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
[TBL] [Abstract][Full Text] [Related]
5. Treat cancers by targeting survivin: just a dream or future reality?
Coumar MS; Tsai FY; Kanwar JR; Sarvagalla S; Cheung CH
Cancer Treat Rev; 2013 Nov; 39(7):802-11. PubMed ID: 23453862
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy.
Wang S; Xu Y; Chan HF; Kim HW; Wang Y; Leong KW; Chen M
J Control Release; 2016 Oct; 240():454-464. PubMed ID: 27091696
[TBL] [Abstract][Full Text] [Related]
7. Is survivin the potential Achilles' heel of cancer?
Lladser A; Sanhueza C; Kiessling R; Quest AF
Adv Cancer Res; 2011; 111():1-37. PubMed ID: 21704829
[TBL] [Abstract][Full Text] [Related]
8. Survivin as a preferential target for cancer therapy.
Mobahat M; Narendran A; Riabowol K
Int J Mol Sci; 2014 Feb; 15(2):2494-516. PubMed ID: 24531137
[TBL] [Abstract][Full Text] [Related]
9. Survivin Small Molecules Inhibitors: Recent Advances and Challenges.
Albadari N; Li W
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771042
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers.
Singh N; Krishnakumar S; Kanwar RK; Cheung CH; Kanwar JR
Drug Discov Today; 2015 May; 20(5):578-87. PubMed ID: 25433305
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of apoptosis: clinical implications in cancer.
Mohamed MS; Bishr MK; Almutairi FM; Ali AG
Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
[TBL] [Abstract][Full Text] [Related]
12. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.
Khan Z; Khan AA; Yadav H; Prasad GBKS; Bisen PS
Cell Mol Biol Lett; 2017; 22():8. PubMed ID: 28536639
[TBL] [Abstract][Full Text] [Related]
13. Survivin Modulators: An Updated Patent Review (2011-2015).
Roy K; Singh N; Kanwar RK; Kanwar JR
Recent Pat Anticancer Drug Discov; 2016; 11(2):152-69. PubMed ID: 26924735
[TBL] [Abstract][Full Text] [Related]
14. Targeting survivin in cancer therapy.
Pennati M; Folini M; Zaffaroni N
Expert Opin Ther Targets; 2008 Apr; 12(4):463-76. PubMed ID: 18348682
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology based platforms for survivin targeted drug discovery.
Samarasinghe RM; Gibbons J; Kanwar RK; Kanwar JR
Expert Opin Drug Discov; 2012 Nov; 7(11):1083-92. PubMed ID: 22950742
[TBL] [Abstract][Full Text] [Related]
16. Survivin as a prognostic/predictive marker and molecular target in cancer therapy.
Rödel F; Sprenger T; Kaina B; Liersch T; Rödel C; Fulda S; Hehlgans S
Curr Med Chem; 2012; 19(22):3679-88. PubMed ID: 22680927
[TBL] [Abstract][Full Text] [Related]
17. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target.
Fang XL; Cao XP; Xiao J; Hu Y; Chen M; Raza HK; Wang HY; He X; Gu JF; Zhang KJ
J Drug Target; 2024 Dec; 32(3):223-240. PubMed ID: 38252514
[TBL] [Abstract][Full Text] [Related]
18. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells.
Sam S; Sam MR; Esmaeillou M; Safaralizadeh R
Pathol Oncol Res; 2016 Oct; 22(4):715-23. PubMed ID: 27055667
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
Varfolomeev E; Vucic D
Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
[TBL] [Abstract][Full Text] [Related]
20. Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II.
Ballot C; Jendoubi M; Kluza J; Jonneaux A; Laine W; Formstecher P; Bailly C; Marchetti P
Apoptosis; 2012 Apr; 17(4):364-76. PubMed ID: 22127645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
